# OnCo record jy231 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/jy231/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "jy231" ;
  schema:name "JY231"@en ;
  schema:alternateName "JY231 Injection"@en ;
  schema:description "JY231 is an experimental in vivo CAR-T therapy from Genocury Biotech, in early studies for B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukaemia."@en ;
  schema:url <https://onco.cc/drugs/jy231/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06678282>, <https://clinicaltrials.gov/study/NCT06890065> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "In vivo CAR-T (an infusion that makes CAR-T cells inside the body)" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:companies <https://onco.cc/companies/genocury-biotech/> ;
  onco:trials <https://onco.cc/trials/nct06678282/>, <https://onco.cc/trials/nct06890065/> .